Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pathophysiol. Aug 15, 2014; 5(3): 188-199
Published online Aug 15, 2014. doi: 10.4291/wjgp.v5.i3.188
Table 6 Pathobiological studies of intrahepatic cholangiocarcinoma 3
SourcenMethodTargetConclusion
Li et al[56]-TissuesmiR-214(-)increased expression of Twist(EMT
-associated gene)
Gu et al[57]123IHCIL-17cells(+)poor prognosis
(intratumoral)
Higashi et al[58]63IHCMUC16(+)poor prognosis
Gu et al[59]83IHCE-cadherin(-)poor prognosis
Beta-catenin(-)V
EGFR(+)Por
Wang et al[60]77IHCP-70S6K(+)Por
4EBP1(+)poor prognosis
Hirashita et al[61]35IHCMMP-7(+)poor prognosis
Srimunta et al[62]55IHCABCC-1(+)poor prognosis
Morine et al[63]35IHCHDAC(+)advanced stage, LN
poor prognosis
Wakai et al[64]34IHCRRM1(+)gemcitabine resistance
Larbcharoensub et al[65]60IHCABCG2(-)poor prognosis, LN, Por
Lee et al[66]101IHCPTEN(+)favorable prognosis
P-AKT1(+)favorable prognosis
P-MTOR(+)favorable prognosis
Dong et al[67]108IHCBeclin1(-)LN, poor prognosis
Shinozaki et al[68]83IHCClaudin-18(+)LN, PI-type, perineural invasion
Wakai et al[69]34IHCNQO1(-)Por, poor prognosis
Aishima et al[70]110IHCS100P(+)PI-type
S100P(nuc)(+)LN, V
Zhou et al[71]89IHCMAGE3/4(+)larger tumor size, poor prognosis